Cleo Diagnostics (ASX:COV) Earnings per Share (Diluted) : A$ (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Earnings per Share (Diluted)?

Cleo Diagnostics's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was A$-0.02.

Cleo Diagnostics's EPS (Basic) for the six months ended in Dec. 2023 was A$-0.02.

Cleo Diagnostics's EPS without NRI for the six months ended in Dec. 2023 was A$-0.02.

Cleo Diagnostics Earnings per Share (Diluted) Historical Data

The historical data trend for Cleo Diagnostics's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Earnings per Share (Diluted) Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Earnings per Share (Diluted)

-0.07

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Earnings per Share (Diluted)	-	-0.03	-0.02

Competitive Comparison of Cleo Diagnostics's Earnings per Share (Diluted)

For the Medical Devices subindustry, Cleo Diagnostics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's PE Ratio falls into.

Cleo Diagnostics Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Cleo Diagnostics's Earnings Per Share (Diluted) for the fiscal year that ended in Jun. 2023 is calculated as

Diluted Earnings Per Share (A: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-1.73	-	0)	/	26.260
	=	-0.07

Cleo Diagnostics's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-2.611	-	0)	/	128.500
	=	-0.02

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Cleo Diagnostics (ASX:COV) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Cleo Diagnostics Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines